Delivery Order SPE2DB22D1106-SPE2DB25FDUR7
Award Date
1/15/25
Potential Completion Date
1/16/25
Potential Value
$3.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,055.93 firm fixed-price delivery order is for the supply of Rexulti 1 mg tablets, a prescription medication. The contract has a completion date of February 21, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $3,315.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Rexulti 1 mg tablets and is a firm-fixed-price delivery order with an ultimate completion date of October 30, 2023. The contract is not designated as a set-aside and was awarded as part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a $3,854.64 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical supplier to the federal government. This order is for the drug Rexulti (0.25 mg tablet, 30s) and has a completion date of May 21, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This IDC serves as the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $18,788.81, is for the delivery of the antipsychotic medication Rexulti 1 mg tablets. This is a firm fixed price delivery order contract with a completion date of September 26, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999...
This federal contract award, worth $6,313.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Rexulti 1 mg tablets, a medication used to treat certain mental health conditions. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award is for the delivery of pharmaceutical products, specifically the medication Rexulti 1 mg tablet, to the Defense Logistics Agency (DLA). The contract, valued at $4,866.53, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order that runs until February 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation, is a delivery order valued at $11,081.84 for the supply of the pharmaceutical product Rexulti 2 mg tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency of the U.S. Department of Defense, and has a period of performance through March 27, 2024. This delivery order is placed under a larger indefinite delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,035.66 firm fixed-price delivery order is for 4564898835 REXULTI 1 MG TABLET 30S, a pharmaceutical product. The contract has a completion date of June 14, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) and has a ceiling value of $5,067.83. The contract is a delivery order for the supply of REXULTI 1 MG TABLET 30S, a pharmaceutical product, to support federal healthcare programs. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen also holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,550.23 firm fixed-price delivery order is for the supply of the prescription medication REXULTI 2 MG TABLET 30S. The contract has an ultimate completion date of December 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...